Women's Health Issues
Volume 18, Issue 5 , Pages 347-350 , September 2008

Insured Women and Payment for Elective Abortion

  • J.A. Lee, ScM

      Affiliations

    • Health Care Systems Department, the Wharton School, University of Pennsylvania, Philadelphia, Pennsylvania
    • Corresponding Author InformationCorrespondence to: J. Andrew Lee, ScM, Health Care Systems Department, The Wharton School, University of Pennsylvania, 3641 Locust Walk, Philadelphia, PA 19104; Fax: 808-946-8060
    • J. Andrew Lee is a doctoral candidate in the Health Care Systems Department at the Wharton School, University of Pennsylvania. His research focuses on the economics of medical care delivery as well as the strategic leadership and governance of health care organizations.
    • ,
  • Aimee Afable-Munsuz, PhD

      Affiliations

    • University of California, San Francisco, San Francisco, California
    • Aimee Afable-Munsuz's research has focused on understanding the social factors that influence access to healthcare and medical technology among underserved populations. She has worked primarily in the areas of reproductive health and cancer prevention.
    • ,
  • Stephanie L. Van Bebber, MSc

      Affiliations

    • Department of Clinical Pharmacy, University of California, San Francisco, San Francisco, California
    • Stephanie Van Bebber's work has focused on a wide range of interests in health services research and health policy including women's health.
    • ,
  • Kathryn A. Phillips, PhD

      Affiliations

    • Department of Clinical Pharmacy, University of California, San Francisco, San Francisco, California
    • Kathryn Phillips' research focuses on how health care is organized, delivered, and financed in the United States, particularly the impact of personalized medicine and targeted therapies on clinical practice and health policy. She has a long interest in women's reproductive health.

Received 20 December 2007 ,Revised 14 March 2008 ,Accepted 16 March 2008.

References 

  1. Afable-Munsuz A, Gould H, Stewart F, Phillips KA, Van Bebber SL, Moore C. Provider practice models for and costs of delivering medication abortion—Evidence from 11 US abortion care settings. Contraception. 2007;75:45–51
  2. Dnadirect.com. Breast & ovarian cancer. www.dnadirect.comAccessed June 22, 2007
  3. Finer LB, Henshaw SK. Abortion incidence and services in the United States in 2000. Perspectives on Sexual and Reproductive Health. 2003;35:6–15
  4. Gemperli MP, Stewart FH, Phillips KA, Sakowski J, Van Bebber SL, Bergthold L. A qualitative study of insurers' coverage for mifepristone-induced abortion. Managed Care Interface. 2005;18:26–30
  5. Grimes DA, Creinin MD. Induced abortion: An overview for internists. Annals of Internal Medicine. 2004;140:620–626
  6. Guttmacher Institute. Facts on induced abortion in the United States. Guttmacher Institute; 2006;In brief. Available: www.guttmacher.org. Accessed June 10, 2007
  7. Guttmacher Institute. Restricting insurance coverage of abortion. Guttmacher Institute; 2007;State policies in brief. Available: www.guttmacher.org. Accessed June 22, 2007
  8. Gwyn K, Vernon SW, Conoley PM. Intention to pursue genetic testing for breast cancer among women due for screening mammography. Cancer EpidemiologyBiomarkers & Prevention. 2003;12:96–102
  9. Henshaw SK, Finer LB. The accessibility of abortion services in the United States, 2001. Perspectives on Sexual and Reproductive Health. 2003;35:16–24
  10. Kaiser Family Foundation. Women's health insurance coverage (Fact sheet: Women's health policy facts). www.kff.org/Accessed December 4, 2007
  11. Lawrence WF, Peshkin BF, Liang W, Isaacs C, Lerman C, Mandelblatt JS. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations. Cancer EpidemiologyBiomarkers & Prevention. 2001;10:475–481
  12. Lee SC, Berhardt BA, Helzlsouer KJ. Utilization of BRCA1/2 genetic testing in a clinical setting. Cancer. 2002;94:1876–1885
  13. Ludman E, Curry SJ, Hoffman E, Taplin S. Women's knowledge and attitudes about genetic testing for breast cancer susceptibility. Effective Clinical Practice. 1999;2:158–162
  14. National Abortion Federation. Medical abortion/history and overview. www.prochoice.orgAccessed December 12, 2007
  15. Sonfield A, Gold RB, Frost JJ, Darroch JE. U.S. insurance coverage of contraceptives and the impact of contraceptive coverage mandates, 2002. Perspectives on Sexual and Reproductive Health. 2004;36:72–79
  16. Sugerman S, Halfon N, Fink A, Anderson M, Valle L, Brook RH. Family planning clinic patients: Their usual health care providers, insurance status, and implications for managed care. Journal of Adolescent Health. 2000;27:25–33
  17. Van Bebber SL, Phillips KA, Weitz TA, Gould H, Stewart FH. Patient costs for medication abortion: Results from a study of five clinical practices. Women's Health Issues. 2006;16:4–13

 Funded by the David and Lucile Packard Foundation.

PII: S1049-3867(08)00039-X

doi: 10.1016/j.whi.2008.03.003

Women's Health Issues
Volume 18, Issue 5 , Pages 347-350 , September 2008

Article Tools